
UAE petrol prices to drop marginally in August
Petrol prices rose sharply in July after being kept steady in June following a marginal increase in May. Prices were reduced in March and April, following a rise of about 5 per cent in February. Fuel rates were unchanged in January.
How much will fuel cost in August 2025?
The breakdown of fuel prices per litre for next month is as follows:
Super 98: Dh2.69, compared to Dh2.7 in July
Special 95: Dh2.57, compared to Dh2.58 in July
Diesel: Dh2.78, compared to Dh2.63 in July
E-Plus 91: Dh2.50, compared to Dh2.51 in July
The UAE deregulated fuel prices in 2015 and movements are now tied to those in the global oil market, which has experienced significant volatility since the beginning of the year.
Concerns about a global economic slowdown due to US President Donald Trump's tariffs on trade partners, and retaliatory measures, have put pressure on oil prices.
Oil prices have increased this week on the prospects of a potential supply shortage after Mr Trump gave Moscow a shorter deadline to end the war in Ukraine.
Mr Trump said he would start imposing measures on Russia, such as secondary tariffs of 100 per cent on trading partners, if it did not make progress on ending the war within 10 to 12 days, moving from an earlier 50-day deadline.
He said he was not concerned about the impact on the market, suggesting the US could ramp up production. 'I don't even worry about it,' he said on Tuesday. 'We have so much oil in our country. We'll just step it up, even further.'
The US had warned China, the largest buyer of Russian oil, that it could face significant tariffs if it kept buying, Treasury Secretary Scott Bessent told a news conference in Stockholm.
JP Morgan analysts said in a note that while China was not likely to comply with US sanctions, India has signalled it would do so, putting at risk 2.3 million barrels per day of Russian oil exports.
"Trump's 10-day ultimatum to [Russian President Vladimir] Putin to sign a Ukraine ceasefire deal has injected about $4 to $5 per barrel supply risk premium in crude, overcoming a drag from a sustained sluggish oil demand growth outlook and an accelerated unwinding of Opec+ cuts," Vandana Hari, chief executive of Singapore-based Vanda Insights, told The National.
"In the days and weeks ahead, how the Ukraine standoff is resolved – or not – may hold the key to crude prices. I expect Trump would not impose such harsh sanctions against Russian oil that they cause a price spike. But one can't completely bet on it."
The oil market faced extreme volatility in June, primarily driven by the 12-day Israel-Iran conflict. Brent prices touched a five-month high of more than $81 a barrel, before erasing all gains as the two countries agreed to a fragile ceasefire.
Crude prices started the year strongly. The closing price of Brent peaked at more than $82 a barrel on January 15, while West Texas Intermediate hit almost $79 per barrel on that day.
However, demand concerns, a slowing global economy and less-than-stellar growth in China, the world's biggest crude importer, have weighed on crude prices this year. Mr Trump's push to impose hefty tariffs on trade partners has been the biggest driver of declining oil prices.
Markets remain focused on the US deadline to nail down trade deals by August 1, and the Opec+ meeting over the weekend that will decide supply for September.
In July, Opec+ agreed to a larger-than-anticipated increase in its monthly oil output, by 548,000 barrels per day, for August. The decision marked the fifth consecutive month that the group of oil producers, led by Saudi Arabia and Russia, agreed to raise production.
However, the latest increase was a jump from the 411,000 barrels per day for each of May, June and July. The group had approved an increase of 138,000 barrels per day in April.
"The Opec+ group of 8 will likely push through a final tranche of 548,000 bpd increase in target for September," Ms Hari said.
"The market has mostly baked in that outcome, though the decision may initially exert some downward pressure on crude, especially if the Russia geopolitical risk premium has abated or settled into a holding pattern by then."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
9 minutes ago
- Zawya
US Investment Bank H.C. Wainwright reiterates buy rating on IHC portfolio company, Phoenix Group, with AED 3.00 target
Abu Dhabi, UAE: Phoenix Group PLC (ADX: PHX), an IHC portfolio company and a global leader in blockchain and digital asset infrastructure, has been featured in a new research report from H.C. Wainwright & Co. Independent equity analysts at H.C. Wainwright & Co. have assigned Phoenix Group a Buy rating and AED 3.00 price target, recognizing its evolution beyond mining into high-growth AI and HPC infrastructure. Based on the August 4, 2025, closing price of AED 1.48, the report states an enormous upside potential in excess of 102% for the shares. The positive assessment is underpinned by Phoenix Group's strategic expansion and its forward-looking ambitions in high-growth technology sectors. The report, titled 'Re-Energized Sites and AI/HPC Feasibility Prime Upside; Reit. Buy,' underscores Phoenix Group's strong position for meaningful growth in both the near and long term. The reaffirmed Buy rating is supported by a shift to higher-margin self-mining, expanding operational capacity, and significant digital asset holdings of BTC and Solana in excess of 150 million USD. The analysis highlights Phoenix's diversified strategy, which balances efficient digital asset mining with strategic investment in next-generation sectors such as Artificial Intelligence (AI) and High-Performance Computing (HPC). It also notes the company's ability to attract ongoing capital support amid broader industry trends that favour advanced connectivity and compute infrastructure. With new sites expected to come online, Phoenix is well-positioned to meet growing demand for AI workloads and unlock additional revenue streams. Central to this momentum is Phoenix's established partnership with IHC (IHC: ADX), the Abu Dhabi-based diversified investment firm. As a valued IHC portfolio company, Phoenix leverages shared expertise and resources to scale operations and execute on innovative projects, bolstering its resilience in a dynamic market. 'We are delighted that H.C. Wainwright sees the significant value and enormous potential in our strategy,' said Munaf Ali, CEO and Co-founder of Phoenix Group. 'This report validates our team's hard work to expand our core mining operations efficiently while boldly moving into the AI and HPC space. As an IHC portfolio company, we are committed to driving innovation and delivering superior returns for our shareholders, and this report confirms we are on the right path.' While the report acknowledges sector-specific risks, including digital asset market volatility, it expresses confidence in Phoenix's strategic trajectory and competitive positioning. Full details of Phoenix Group's Q2 2025 results and the analyst report are available on the company's Investor Relations page. About Phoenix Group Phoenix Group PLC, an IHC Portfolio Company, is a multi-billion-dollar global technology leader headquartered in Abu Dhabi, UAE. As one of the world's top ten Bitcoin miners, it operates over 500 megawatts across the UAE, U.S., Canada, Oman, and Ethiopia, running the biggest mining farm in MENA. Phoenix Group is the first crypto and blockchain conglomerate in the region to be listed on the Abu Dhabi Securities Exchange (ADX). Media Enquiries: media@


Zawya
9 minutes ago
- Zawya
RAKEZ partners with Rana Group to set up Erisha Smart Manufacturing Hub in Ras Al Khaimah
New Delhi : Ras Al Khaimah Economic Zone entered into a landmark partnership with Indian construction giant Rana Group to establish Erisha Smart Manufacturing Hub – a groundbreaking initiative that aims to revolutionise the region's industrial and sustainability sectors. The collaboration is set to pave the way for the operational expansion of the Group's EV subsidiary Erisha E Mobility in the Middle East and Africa, while strengthening its existing business in India. Erisha Smart Manufacturing Hub will be a state-of-the-art facility spanning 15 million ft2, with an expansive total construction area of approximately 25 million ft2. The hub will support over 150 industries, focusing on pioneering technologies such as electric and hydrogen vehicle production, renewable energy, EVTOL (electric vertical take-off and landing) aircraft, and semiconductor manufacturing. Through this innovative Hub, the company aims to create a sustainable and technologically advanced ecosystem, seamlessly integrating industrial, residential, and commercial spaces. It will house a wide range of facilities, including hospitals, medical colleges, shopping complexes, hypermarkets, warehouses, office spaces, community centres, banks, and financial institutions. The mixed-use development will span 335 acres and is expected to attract approximately USD 10 billion in investment. Once operational, it will contribute an estimated USD 5-6 billion to the UAE's GDP and generate around 4,000 jobs in Ras Al Khaimah. Erisha E Mobility Chairman and Managing Director Dr Darshan Rana commented, 'We are thrilled to partner with RAKEZ and bring Erisha Smart Manufacturing Hub to life. This project will be at the forefront of the green energy revolution, contributing significantly to the UAE's net zero ambitions and creating a self-sustainable future. Our goal is to set new benchmarks in sustainable industrialisation, driving innovation while supporting the global transition to cleaner energy solutions.' RAKEZ Group CEO Ramy Jallad said, 'Ras Al Khaimah continues to establish itself as a fertile base for technological innovation and sustainable development. With its robust infrastructure, strategic location, and dynamic business environment, the emirate is well-positioned to support forward-thinking initiatives like Erisha Smart Manufacturing Hub. While this integrated Hub will drive economic diversification, it will also create thousands of new jobs, promoting long-term growth and reinforcing Ras Al Khaimah's leadership in green energy and advanced manufacturing.' This partnership underscores a shared commitment to driving sustainability, innovation, and economic growth. RAKEZ, with its world-class infrastructure and commitment to fostering business success, provides the ideal platform for Erisha E Mobility's global expansion, ensuring that the Hub will be a catalyst for progress in the UAE and beyond.


Zawya
9 minutes ago
- Zawya
Burjeel Holdings reports 129% increase Q2'25 net profit, with accelerated revenue growth
Abu Dhabi, United Arab Emirates: Burjeel Holdings PLC ('Burjeel' or 'the Group'), a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its financial results in accordance with International Financial Reporting Standards (IFRS) for the three-month and six-month periods ended 30 June 2025. Executing with Focus: Specialized Services, Efficiency, and Expansion Burjeel Holdings accelerated its strategic execution in Q2 2025 with a series of high-impact initiatives that deepened specialization and broadened patient access. The Group expanded its advanced oncology network, integrating Dubai's Advanced Care Oncology Center and opening new Burjeel Cancer Institute (BCI) clinics in Al Ain, Sharjah, and Oman, reinforcing its position as a regional leader in complex cancer care. The UAE's first dedicated cancer pharmacy was also inaugurated, strengthening oncology support infrastructure. In parallel, Burjeel launched a regional mental health platform through its joint venture Alkalma, opening four specialist mental health centers across the UAE and Saudi Arabia. This marked the first phase of a multi-year expansion strategy aimed at addressing rising demand for mental wellness services. In Saudi Arabia, the Group acquired a major physiotherapy facility in Riyadh under the PhysioTherabia platform, adding scale and unlocking turnaround potential through secured government contracts. Investments in operational resilience and access continued with the AED 170 million acquisition of the Medeor Hospital Dubai building, converting long-term lease obligations into ownership and enhancing cost structure flexibility. The Group also expanded its primary care footprint with a new medical center launched on Saadiyat Island, aligning with its growth strategy in high-yield urban catchments. In medical innovation, Burjeel launched DOCKTOUR, a transformative healthcare logistics joint venture with AD Ports Group, aiming to redefine how medical services and infrastructure are delivered to underserved and remote communities. Several specialized centers were introduced, including the region's first Al Muderis Osseointegration Clinic for advanced limb reconstruction, a state-of-the-art Epilepsy Monitoring Unit, and expanded capabilities in rare diseases, hematology, and metabolic research. Additionally, the Group continued its digital transformation with AI-powered diagnostics and led groundbreaking research in microgravity, aiming to transform care for patients with diabetes in space and on Earth. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimization, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities. The Alkalma mental health platform is scaling regionally, alongside rehabilitation services through over 30 PhysioTherabia centers in Saudi Arabia. Additionally, we introduced the region's first Osseointegration Clinic for cutting-edge prosthetic care. 'In parallel with expanding our network of primary care and medical centers, we deepened partnerships with government and corporate stakeholders and accelerated digital integration through Oracle Health EMR and AI-powered tools. Building on this platform, we entered into pivotal partnerships in oncology, value-based care, diagnostics, and international healthcare innovation, establishing the Group as the healthcare partner of choice. 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value. Net profit growth of 129% in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.' Q2'25: Growth Delivered, Efficiency Embedded Burjeel Holdings delivered strong top-line growth of 18.7% to AED 1,403 million in Q2'25, driven by a 12.1% increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network. Revenue in H1'25 rose 12.2% to AED 2,677 million, with total patient visits reaching 3.4 million. Oncology remained a core growth driver, with revenue rising 36.7% in Q2'25 and 38.1% in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18%), emergency medicine (+17%), cardiology (+16%), and gastroenterology (+13%). Inpatient footfall rose 17.7% in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. The Group performed 22,930 surgeries, up 18.7%, with momentum concentrated at Burjeel Medical City, Burjeel Specialty Hospital Sharjah, Lifecare Hospital Musaffah and Burjeel Royal Hospital Al Ain. Bed occupancy improved to 69%, up from 65% a year ago, and averaged 69% in H1'25. Inpatient volumes rose 14.6% over the first half. Outpatient footfall grew 12.0% in Q2'25, accelerating from 5.2% in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilization improved to 68%, up from 65% in Q1'25, enabled by optimized hiring and scaling of clinical teams. Leading facilities included Burjeel Medical City, Lifecare Hospital Baniyas, and Burjeel Day Surgery Center Barari. In H1'25, outpatient volumes increased 8.6%. EBITDA rose 59.4% to AED 306 million in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED 72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 p.p. to 21.8%. In H1'25, EBITDA increased 14.2% to AED 487 million, with a margin of 18.2%. Net profit surged 128.9% to AED 148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED 187 million. Hospitals Lead Growth, Medical Centers Accelerate The Hospitals segment continued to drive Group performance, contributing 89% of total revenue in Q2'25. Revenue grew 17.3% to AED 1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Segment EBITDA rose by 40.6%, led by strong performance across key hospitals, including Burjeel Medical City, Burjeel Hospital Abu Dhabi, Burjeel Day Surgery Center Barari and Burjeel Royal Hospital Al Ain. The Medical Centers segment also delivered exceptional growth, with Q2'25 revenue rising 36.8% to AED 121 million. This was driven by the successful ramp-up of over 45 new centers across the UAE and Saudi Arabia, expanding access to high-quality outpatient and physiotherapy services. In H1'25, Medical Centers revenue increased 26.7% to AED 229 million, reflecting the Group's strong momentum in scaling primary care. BMC: Scaling Patient Base & Driving Efficiency Gains Burjeel Medical City (BMC), the Group's flagship facility, remained a key growth engine, achieved 14.7% growth in revenue to AED 333 million, driven by a 30.4% increase in patient volumes. This performance was underpinned by a higher outpatient share, strong oncology momentum, and robust post-Ramadan demand for minimally invasive and elective procedures. Bed occupancy improved to 68%, underscoring stronger inpatient utilization. Revenue from BMC in H1'25 increased 13.0% to AED 648 million. BMC EBITDA rose 21.3% to AED 59 million in Q2'25, with the EBITDA margin improving to 17.6%. In H1'25, EBITDA grew 20.8% YoY to AED 112 million, with margin expansion of 1.1 p.p. to 17.3%. Profitability growth was supported by scale efficiencies and continued investment in super-specialty services. BMC's performance reinforces its strategic role as the Group's key platform for complex care and future value creation. Disciplined Leverage with Strong Cash Generation Operating cash flow increased 8.1% YoY in H1'25, driven by improved operational performance and disciplined working capital management. Maintenance CAPEX remained in line with guidance, while Growth CAPEX totaled AED 403 million, driven by strategic M&A activities and ongoing network expansion. Free cash flow (FCF)1 conversion improved to 54% in H1'25. The Group's net debt / pre-IFRS 16 LTM EBITDA2 stood at 1.8x as of 30 June 2025, reflecting the acquisition of the Dubai hospital building. This strategic transaction enhanced asset ownership while optimizing the Group's cost structure. The Group maintains a strong and flexible balance sheet, enabling continued investment in growth opportunities. With no contingent off-balance sheet liabilities, management remains focused on optimizing capital structure through debt reduction, refinancing, and tenure extension. Dividend Policy Burjeel Holdings is committed to delivering value to stakeholders while ensuring alignment with strategic growth plans. The Group maintains a dividend policy with a payout range of 40–70% of net income, depending on investment needs for expansion. In May 2025, the Group declared a full-year dividend of AED 170 million for FY2024, representing 47% of net profit. This reflects strong profitability and a balanced approach to rewarding shareholders while supporting long-term growth. About Burjeel Holdings Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. The Group operates an integrated and multi-brand healthcare ecosystem across primary, secondary, tertiary, and quaternary medical care, ensuring complex care delivery to patients across all socioeconomic groups. Its network comprises 112 assets across the UAE, Oman, and Saudi Arabia, including 20 hospitals, 37 medical centers, 30 physiotherapy and wellness centers, 15 pharmacies, and 10 other allied services. Burjeel Holdings' brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia, Alkalma, and Tajmeel.